ESMO Preceptorship on Immuno-Oncology Amsterdam 2016

Oncology Meeting Resources

30 Sep - 01 Oct, Amsterdam, Netherlands

ESMO Preceptorship on Immuno-Oncology

Main learning objectives for the ESMO Preceptorship on Immuno-Oncology Amsterdam 2016 included understanding the basics of tumour immunology; learning about the essentials of immunotherapies and their applications in cancer medicine; learning about the status of development and clinical experience of immunotherapy in different tumour types.

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
R. A. Stahel, CH Historical Introduction Historical Introduction
L, Buisseret, BE Breast Cancer Session 2 Clinical Development
J. Larkin, UK Renal Cell Cancer Session 2 Clinical Development
M. van der Heijden, NL Bladder Cancer Session 2 Clinical Development
P. Kvistborg, NL Functional Assessment of Immune Responses and Identification of New Antigens Session 3 Immunomonitoring
T. Winder, CH Colorectal Cancer Session 4 Lung Cancer, Thoracic Cancer and Colon Cancer
R. A. Stahel, CH Thoracic Malignacies Session 4 Lung Cancer, Thoracic Cancer and Colon Cancer
J.B.A.G.Hannen, NL Biomarkers for Immunotherapy Session 5 Biomarkers and Tumour Antigens
C. Linnemann, NL Tumour Antigens Session 5 Biomarkers and Tumour Antigens
H. Joyce, UK Management of a Melanoma Case Session 6 Audience Cases
C. L. Lee, IE Melanoma - Presumably an Immune-Related AE Session 6 Audience Cases
U. Asghar, UK Triple negative breast cancer - under control Session 6 Audience Cases
L. Del Carpio Huerta, ES NSCLC Mixed Response to Nivolumab: Extra Cranial Response and Progressive Brain Disease Session 6 Audience Cases
P. Martin Martorell, ES Response of CNS Metastasis of NSCLC to Anti PD1 Inmunotherapy Session 6 Audience Cases
K. Bol, NL Vaccines and immunomonitoring Session 7 Essentials in Immunotherapies